Amgen, a pioneer in biotechnology, have been at the forefront of developing medicines with a commitment to innovation, integrity, and excellence.
From oncology treatments that target solid tumour and haematological malignancies, immunosuppressants for plaque psoriasis, cardiovascular products to treat cholesterol disorders, bone health medicines for osteoporosis in postmenopausal women, our diverse portfolio is testament to our dedication to scientific advancement.
Enhance your clinical decisions and support patient care with evidence-based data and resources.
